Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Astria Therapeutics, Inc. (ATXS) had Weighted-Average Shares Outstanding (Diluted) of 58.01M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-33.71M |
|
-- |
|
-- |
|
$36.99M |
|
$-36.99M |
|
$3.29M |
|
$-33.71M |
|
$-33.71M |
|
$-33.71M |
|
$-33.71M |
|
$-33.71M |
|
$-33.71M |
|
$-36.99M |
|
$-36.99M |
|
58.01M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
58.01M |
$-0.58 |
|
$-0.58 |
|
| Balance Sheet Financials | |
$302.97M |
|
-- |
|
$7.42M |
|
$310.39M |
|
$17.43M |
|
-- |
|
$99.00M |
|
$116.42M |
|
$193.97M |
|
$193.97M |
|
$193.97M |
|
56.43M |
|
| Cash Flow Statement Financials | |
$-34.02M |
|
$28.58M |
|
$0.00M |
|
$59.82M |
|
$54.38M |
|
$-5.43M |
|
$3.84M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
17.39 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-34.02M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-17.38% |
|
-17.38% |
|
-10.86% |
|
-17.38% |
|
$3.44 |
|
$-0.59 |
|
$-0.59 |
|